In contrast preincubation of Jc1 variants with 10 μg/ml hCD81 LEL reduced infection by these viruses more than 10-fold, suggesting that both adapted variants are more susceptible to inhibition by soluble human CD81 protein (Figure 3A). The gene discussed is CD81; the disease is infection.